Melissa Starovasnik
Vice President, Protein Sciences
"Genentech provides a highly stimulating working environment where one regularly interacts with bright and talented individuals, who inspire creativity and success and are all motivated by a strong shared desire to discover and develop important medicines that will make a difference in patients' lives."
- 20
years at Genentech - 8
publications (2010-12) - 4
awards & honors
I came to Genentech first as a postdoctoral fellow in the protein NMR group in 1993, and was hired as a scientist in Protein Engineering in 1995. I was drawn to pursue research here because of the exciting and high-quality science taking place; our highly collaborative, multidisciplinary approach; and the opportunity to work with exceptionally talented colleagues. Throughout my time here, I have been involved in many exciting projects, all sharing the common theme of exploring protein/peptide structure and function, with an emphasis on the study of molecular recognition and application to drug development.
My role has broadened significantly in recent years, where I now have both scientific and operational responsibilities within our research organization. On the science side, I lead the Structural Biology department encompassing high-throughput protein expression, NMR spectroscopy, and X-ray crystallography, with the aim to provide a detailed structural understanding of the molecular nature of our drug targets and candidates. While on the operations side, I oversee all operational activities for our 1300-member research organization, and serve on the research leadership team.
Featured Publication
Engineering human IgG1 affinity to human neonatal Fc receptor: impact of affinity improvement on pharmacokinetics in primates
J Immunol 2009 Jun 15; 182(12): 7663-71
Yeung YA, Leabman MK, Marvin JS, Qiu J, Adams CW, Lien S, Starovasnik MA, Lowman HB
View Abstract on PubMed
